Bagmane Prime Office REIT IPO Day 2: GMP ₹5

Welcome back to our daily dose of IPO insights! We’re on Day 2 of the Bagmane Prime Office REIT IPO on the NSE mainboard, and the subscription numbers are still holding steady at zero across all categories. Yes, you read that right – 0x for Retail, NII, QIB, and the total. With the IPO period running from May 5th to May 7th, 2026, and an issue price of ₹95 per share, the market is yet to make its move. Let’s dive into what this quiet start might mean.

Subscription Status

The complete lack of subscription on Day 2 is certainly an eyebrow-raiser. Typically, by the second day, we’d expect to see at least some initial interest, especially from retail investors. The fact that Retail, NII (Non-Institutional Investor), and QIB (Qualified Institutional Buyer) categories are all showing 0x subscription indicates a very cautious market sentiment, or perhaps investors are waiting for more information or a clearer direction. For QIBs, their participation is often a strong indicator of institutional confidence. Their absence so far doesn’t necessarily mean doom, but it’s definitely something to keep an eye on. Similarly, NIIs usually jump in when they see a compelling opportunity. The current numbers suggest they’re holding back. The lot size being 0 shares is also unusual and likely a placeholder or an error in the provided data, as a lot size of zero would mean no shares can be traded in a single lot, which is not how IPOs function. We’ll assume a standard lot size will be confirmed and become active soon.

GMP Update

Moving on to the Grey Market Premium (GMP), we’ve seen a bit of stability, which is good news. The current GMP stands at ₹5, unchanged from yesterday. This suggests that the market’s initial valuation for Bagmane Prime Office REIT post-listing is around ₹100 (Issue Price of ₹95 + GMP of ₹5). While a ₹5 GMP isn’t a massive indicator of overwhelming demand, it does show a positive sentiment, albeit a mild one. The fact that it hasn’t dipped is encouraging, especially given the subdued subscription numbers. It implies that some market participants are still willing to pay a premium for the shares, anticipating a small gain on listing day. However, this is a relatively low GMP, so don’t expect a spectacular listing day surge based on this alone.

Should You Apply?

Deciding whether to apply for the Bagmane Prime Office REIT IPO at this stage requires a balanced perspective. On one hand, the GMP of ₹5, though modest, points towards a potential listing gain. The expected listing price of ₹100, a slight uptick from the issue price, is not unattractive. However, the absolute zero subscription across all categories on Day 2 is a significant concern. It suggests that investors, be they retail, NII, or QIB, are not rushing to subscribe. This could be due to various reasons: perhaps the asset class isn’t currently in vogue, or the company’s fundamentals haven’t resonated strongly yet, or simply that investors are waiting for the final days of the IPO to gauge broader interest. SEBI registered advisors often recommend looking at a combination of factors, including the company’s financials, the REIT’s portfolio quality, market conditions, and subscription levels. Given the current data, it’s a case for caution. If you’re a long-term investor looking for exposure to office spaces and believe in Bagmane Prime’s portfolio, the current low interest might present an opportunity to enter at a potentially better valuation if the subscription picks up slowly. But if you’re looking for a quick listing gain, the current GMP and subscription status might not offer the conviction you’re seeking. It’s crucial to do your own research and consult with financial advisors before making any investment decisions.

View Full Bagmane Prime Office REIT IPO Details